Prevalence of low positive anti-HCV antibodies in blood donors: Schistosoma mansoni co-infection and possible role of autoantibodies

Microbiology and Immunology

Volumn 50, Issue 6, 2006, Pages 447-452

  Agha, Salah ^a   El Mashad, Noha ^a   El Malky, Mohamed ^a   El Shony, Huda ^a   El Sherif, Mohamed Zaki ^a   El Hasan, Mohamed Abo ^a   Tanaka, Yasuhito ^b   Mizokami, Masashi ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Autoantibodies; Blood donors; HCV; Schistosoma mansoni

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; HEPATITIS C VACCINE; IMMUNOGLOBULIN G; MARKER; MITOCHONDRION ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD DONOR; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; LABORATORY; LIVER FUNCTION TEST; MALE; OPTICAL DENSITY; PARASITOSIS; PREVALENCE; QUANTITATIVE ANALYSIS; SCHISTOSOMA MANSONI;

HEPATITIS C VIRUS; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 33745262532     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2006.tb03813.x     Document Type: Article

References (33)

1. Abbas, M.S., and Abdel Kader, S. 1993. A study of autoimmunity in schistosomiasis. J. Egypt Soc. Parasitol. 23: 289-296.
2. Agha, S., Tanaka, Y., Saudy, N., Kurbanov, F., Abo-Zeid, M., El-Malky, M., Khalaf, M., Ohta, N., Yoshizawa, H., and Mizokami, M. 2004. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan. J. Med. Virol. 73: 216-222.
3. Amelia, R., Ilma, A., Olivia, B., Andrea, M., Edward, P., Donald, H., Mette, S., and Edgar, M. 2000. Human immune responses to Schistosoma mansoni vaccine candidate antigens. Infect. Immun. 68: 2797-2803.
4. Chitsulo, L., Engels, D., Montresor, A., and Savioli, L. 2000. The global status of Schistosomiasis and its control. Acta Trop. 77: 40-51.
5. Dalekos, G.N., Wedemeyer, H., Obermayer-Straub, P., Kayser, A., Barut, A., Frank, H., and Manns, M.P. 1999. Epitope mapping of cytochrome p4502D6 autoantigen in patients with chronic hepatitis C during α-interferon treatment. J. Hepatol. 30: 366-375.
6. Deelder, A.M. 1973. Immunology of experimental infections with Schistosoma mansoni in the swiss mouse and with Fasciola hepatica in the rabbit. Acta Leiden. 39: 105-107.
7. Dos Santos, V.A., Azevedo, R.S., Camargo, M.E., and Alves, V.A. 1999. Serodiagnosis of hepatitis C virus. Effect of new evaluation of cutoff values for enzyme linked immunosorbent assay in Brazilian patients. Am. J. Clin. Pathol. 112: 418-424.
8. Dufour, D.R., Talastas, M., Fernandes, M.D., Harris, B., Strader, D.B., and Seeff, L.B. 2003. Low-positive anti hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin. Chem. 49: 479-486.
9. Ekladios, E.M., Ageeb, M., Milad, M., and Khalil, R. 1971. Autoantibodies in hepatic schistosomiasis. Kasr-El-Aini J. Surg. 12: 299-305.
10. El Serag, H.B. 2002. Hepatocellular carcinoma: an epidemiological view. J. Clin. Gastroenterol. 35 (Suppl): S72-78.
11. EL-Zayadi, A.R., Selim, O., Ibrahim, E.H., Hamdy, H., Dabbous, H., Ahdy, A., and Moneim, S.A. 1997. Does schistosomiasis play a role in the high seroprevalence of HCV antibody among Egyptians? Trop. Gastroenterol. 18: 98-100.
12. Engvall, E., and Perlmann, P. 1981. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulins. Immunochemistry 8: 871-874.
13. Frank, C., Mohamed, M.K., Strickland, G.T., Lavanchy, D., Arthur, R.R., Magder, L.S., EL-Khoby, T., Abdel-Wahab, Y., Aly Ohn, E.S., Anwar, W., and Sallam, I. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 (9207): 887-891.
14. Gad, A., Tanaka, E., Orii, K., Rokuhara, A., Nooman, Z., Serwah, A.H., Sohai, M., Yoshizawa, K., and Kiyosawa, K. 2001. Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect. J. Gastroenterol. 36: 753-758.
15. Gianna, D., Claudio, T., and Cesare, C. 2003. A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection. Ann. Hepatol. 2: 76-83.
16. Goncales, N.S., Costa, F.F., Vassallo, J., and Concales, F.L. 2000. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay. Rev. Inst. Med. Trop. Sao Paulo 42: 263-267.
17. Gregorio, G., Choudhuri, Y., and Pensati, R. 2003. Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin. Exp. Immunol. 133: 404-413.
18. Habib, M., Mostafa, K., Abdel-Aziz, F., Magder, L.S., Abdel-Hamid, M., Gamil, F., Madkour, S., Mikhail, N.N., Anwar, W., Strickland, G.T., Fix, A.D., and Sallam, I. 2001. Hepatitis C virus infection in a community in the Nile delta: risk factors for seropositivity. Hepatology 33: 248-253.
19. Kiely, P., Kay, D., Parker, S., and Piscitelli, L. 2004. The significance of third generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third generation immunoassays. Transfusion 44: 1126.
20. Kim, Y.S., Lee, H.S., and Ahn, Y.O. 1999. Factors associated with high ODR positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR. J. Korean Med. Sci. 14: 629-634.
21. Misko, I.S., Cross, S.M., and Khanna, R. 1999. Cross-reactive recognition of viral self and bacteria low ODR peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 96: 2279-2284.
22. Nishiguchi, S., Kuroki, T., and Ueda, T. 1992. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann. Intern. Med. 116: 21-25.
23. Oldstone, M.B. 1998. Molecular mimicry and immune-mediated diseases. FASEB J. 12: 1255-1265.
24. Pawlotsky, J.M., Lonjon, I., Hezode, C., Raynard, B., Darthuy, F., Remire, J., Soussy, C.J., and Dhumeaux, D. 1998. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 27: 1700-1702.
25. Pereira, L.M., McFarlane, B.M., Massarolo, P., Saleh, M.G., Bridger, C., Spinelli, V., Mies, S., and McFarlane, I.G. 1997. Specific liver autoreactivity in Schistosomiasis mansoni. Trans. R. Soc. Trop. Med. Hyg. 91: 310-314.
26. Rokeach, L.A., Haselby, J.A., Meilof, J.F., Smeenk, R.J., Unnasch, T.R., Greene, B.M., and Hoch, S.O. 1991. Characterization of autoantigen calreticulin. J. Immunol. 147: 3031.
27. Saad El-Din, K., Azza, H.E., and Maha, I. 1996. Possible antigenic mimicry between hepatitis C, Schistosomiasis soluble worm antigen (SAWA) and E-coli antigens, First International Symposium on Viral Hepatitis. Cairo, Egypt.
28. Saad, M.A. 1989. Tissue autoantibodies in chronic liver diseases in Egyptian children, M.Sc. Thesis, Ain-Shams University.
29. Schroter, M., Schafer, P., Zollner, B., Polywka, S., Laufs, R., and Feucht, H.H. 2001. Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay. J. Med. Virol. 64: 320-324.
30. Tanaka, Y., Agha, S., Saudy, N., Kurbanov, F., Orito, E., Kato, T., Abo Zeid, M., Khalaf, M., Miyakawa, Y., and Mizokami, M. 2004. Exponential spread of hepatitis C virus genotype 4a in Egypt. J. Mol. Evol. 58: 191-195.
31. Thomas, S., Elhefni, H., Salman, T., Waked, I., Abdel-Hamid, M., Mikhail, N.N., Esmat, G., and Fix, A. 2002. Role of hepatitis C infection in chronic liver disease in Egypt. Am. J. Trop. Med. Hyg. 67 : 436-442.
32. Tobler, L.H., Busch, J., Wilber, R., Dinello, R., Quan, S., Polito, A., Kochesky, R., Bahl, C., Nelles, M., and Lee, S.R. 1994. Evaluation of indeterminate C22-3 reactivity in volunteer blood donors. Transfusion 34: 130-134.
33. Vergani, D. 2000. LKM antibody: getting in some target practice. Gut 46: 449.